Q4 2019 13F Holders as of 31 Dec 2019
-
Type / Class
-
Equity / Common Stock, par value $0.00001 per share
-
Shares outstanding
-
96,015,846
-
Total 13F shares
-
16,265,458
-
Share change
-
+12,571,195
-
Total reported value
-
$227,227,000
-
Price per share
-
$13.97
-
Number of holders
-
40
-
Value change
-
+$175,618,187
-
Number of buys
-
38
Institutional Holders of Cabaletta Bio, Inc. - Common Stock, par value $0.00001 per share (CABA) as of Q4 2019
As of 31 Dec 2019,
Cabaletta Bio, Inc. - Common Stock, par value $0.00001 per share (CABA) was held by
40 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
16,265,458 shares.
The largest 10 holders included
ADAGE CAPITAL PARTNERS GP, L.L.C., 5AM Venture Management, LLC, Cormorant Asset Management, LP, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), BOXER CAPITAL, LLC, Redmile Group, LLC, BAKER BROS. ADVISORS LP, VANGUARD GROUP INC, MILLENNIUM MANAGEMENT LLC, and BlackRock Inc..
This page lists
40
institutional shareholders reporting positions in this security
for the Q4 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.